Literature DB >> 20174820

Differential recruitment of mechanisms for myogenic responses according to luminal pressure and arterial types.

Eun Bok Baek1, Chunzi Jin, Su Jung Park, Kyung Sun Park, Hae Young Yoo, Ju Hong Jeon, Yung E Earm, Sung Joon Kim.   

Abstract

Mechanosensitive nonselective cation channels (NSC(ms)), protein kinase C (PKC), and Rho kinase (ROCK) are suggested as underlying mechanisms for the myogenic contractile response (MR) to luminal pressure (P(lum)). Here we compared relative contributions from these mechanisms using pharmacological inhibitors in rabbit middle cerebral (RbCA), rat middle cerebral (RtCA), rat femoral (RtFA), and rat mesenteric (RtMA) small arteries. Inner diameters of pressurized arteries under various P(lum) were video-analyzed. 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS, 10 microM) was used as a blocker of NSC(ms). In general, RbCA and RtCA showed higher P(lum) sensitivity of MR than RtFA and RtMA. Ten micromolars of DIDS commonly decreased MRs more effectively at low P(lum) (40-60 mmHg) in all tested arteries except RtCA. In RbCA, PKC inhibitors (100 nM of Go6976 or Go6983) decreased the MR at relatively high P(lum) (80-100 mmHg) whereas ROCK inhibitor (Y-27632, 1 microM) showed a P(lum)-independent inhibition. In RtMA and RtCA, PKC inhibitors (Go6976 and Go6983) had no significant effect whereas Y-27632 generally inhibited the MR. In RtFA, neither PKC inhibitor nor Y-27632 alone affected MRs. Interestingly, in the presence of 10 microM DIDS, Go6983 and Y-27632 decreased the MR of RtFA. In RtMA, it was notable that the MR decreased spontaneously on repeated protocol of P(lum) increase, and the 'run-down' could be effective reversed by maxi-K(+) channel blocker (tetraethylammonium or iberiotoxin). In summary, our study shows the variability of MRs according to the arterial types in terms of their pressure sensitivity and underlying mechanisms that are recruited according to P(lum).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20174820     DOI: 10.1007/s00424-010-0791-7

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  30 in total

1.  What's new in the cerebral microcirculation? Landis Award lecture.

Authors:  D D Heistad
Journal:  Microcirculation       Date:  2001-12       Impact factor: 2.628

2.  Transient receptor potential channels regulate myogenic tone of resistance arteries.

Authors:  Donald G Welsh; Anthony D Morielli; Mark T Nelson; Joseph E Brayden
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

3.  Critical role for transient receptor potential channel TRPM4 in myogenic constriction of cerebral arteries.

Authors:  Scott Earley; Brian J Waldron; Joseph E Brayden
Journal:  Circ Res       Date:  2004-10-07       Impact factor: 17.367

Review 4.  Does arterial myogenic tone determine blood flow distribution in vivo?

Authors:  Kim A Dora
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-10       Impact factor: 4.733

Review 5.  The emerging role of Ca2+ sensitivity regulation in promoting myogenic vasoconstriction.

Authors:  Rudolf Schubert; Darcy Lidington; Steffen-Sebastian Bolz
Journal:  Cardiovasc Res       Date:  2008-01       Impact factor: 10.787

6.  Myogenic activation and calcium sensitivity of cannulated rat mesenteric small arteries.

Authors:  E VanBavel; J P Wesselman; J A Spaan
Journal:  Circ Res       Date:  1998-02-09       Impact factor: 17.367

7.  Membrane stretch directly activates large conductance Ca(2+)-activated K+ channels in mesenteric artery smooth muscle cells.

Authors:  A M Dopico; M T Kirber; J J Singer; J V Walsh
Journal:  Am J Hypertens       Date:  1994-01       Impact factor: 2.689

8.  Gq-coupled receptors as mechanosensors mediating myogenic vasoconstriction.

Authors:  Michael Mederos y Schnitzler; Ursula Storch; Simone Meibers; Pascal Nurwakagari; Andreas Breit; Kirill Essin; Maik Gollasch; Thomas Gudermann
Journal:  EMBO J       Date:  2008-11-06       Impact factor: 11.598

9.  Ca2+ sensitization via phosphorylation of myosin phosphatase targeting subunit at threonine-855 by Rho kinase contributes to the arterial myogenic response.

Authors:  Rosalyn P Johnson; Ahmed F El-Yazbi; Kosuke Takeya; Emma J Walsh; Michael P Walsh; William C Cole
Journal:  J Physiol       Date:  2009-04-09       Impact factor: 5.182

10.  Mechanosensitive nonselective cation channel facilitation by endothelin-1 is regulated by protein kinase C in arterial myocytes.

Authors:  Hyang Ae Lee; Eun Bok Baek; Kyung Sun Park; Hoi Jong Jung; Jae Il Kim; Sung Joon Kim; Yung E Earm
Journal:  Cardiovasc Res       Date:  2007-06-29       Impact factor: 10.787

View more
  5 in total

Review 1.  Vascular plasticity in cerebrovascular disorders.

Authors:  Lars I H Edvinsson; Gro Klitgaard Povlsen
Journal:  J Cereb Blood Flow Metab       Date:  2011-05-11       Impact factor: 6.200

2.  Mechanical control of cation channels in the myogenic response.

Authors:  Brian E Carlson; Daniel A Beard
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-13       Impact factor: 4.733

3.  ERK7 is a negative regulator of protein secretion in response to amino-acid starvation by modulating Sec16 membrane association.

Authors:  Margarita Zacharogianni; Vangelis Kondylis; Yang Tang; Hesso Farhan; Despina Xanthakis; Florian Fuchs; Michael Boutros; Catherine Rabouille
Journal:  EMBO J       Date:  2011-08-16       Impact factor: 11.598

4.  PPARγ regulates resistance vessel tone through a mechanism involving RGS5-mediated control of protein kinase C and BKCa channel activity.

Authors:  Pimonrat Ketsawatsomkron; Ramón A Lorca; Henry L Keen; Eric T Weatherford; Xuebo Liu; Christopher J Pelham; Justin L Grobe; Frank M Faraci; Sarah K England; Curt D Sigmund
Journal:  Circ Res       Date:  2012-09-07       Impact factor: 17.367

5.  Maxi-K channel (BKCa) activity veils the myogenic tone of mesenteric artery in rats.

Authors:  Eun Yeong Suh; Ming Zhe Yin; Haiyue Lin; Yin Hua Zhang; Hae Young Yoo; Sung Joon Kim
Journal:  Physiol Rep       Date:  2017-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.